Association with Class IIa Histone Deacetylases Upregulates the Sumoylation of MEF2 Transcription Factors

REFERENCES

• Appella, E., and C. W. Anderson. 2001. Post-translational modifications and activation of p53 by genotoxic stresses. Eur. J. Biochem. 268:2764–2772.
   PubMedGoogle Scholar
• Ayaydin, F., and M. Dasso. 2004. Distinct in vivo dynamics of vertebrate SUMO paralogues. Mol. Biol. Cell 15:5208–5218.
   PubMed Web of Science ®Google Scholar
• Bakin, R. E., and M. O. Jung. 2004. Cytoplasmic sequestration of HDAC7 from mitochondrial and nuclear compartments upon initiation of apoptosis. J. Biol. Chem. 279:51218–51225.
   PubMed Web of Science ®Google Scholar
• Bernier-Villamor, V., D. A. Sampson, M. J. Matunis, and C. D. Lima. 2002. Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1. Cell 108:345–356.
   PubMed Web of Science ®Google Scholar
• Best, J. L., S. Ganiatsas, S. Agarwal, A. Changou, P. Salomoni, O. Shirihai, P. B. Meluh, P. P. Pandolfi, and L. I. Zon. 2002. SUMO-1 protease-1 regulates gene transcription through PML. Mol. Cell 10:843–855.
   PubMedGoogle Scholar
• Bischof, O., O. Kirsh, M. Pearson, K. Itahana, P. G. Pelicci, and A. Dejean. 2002. Deconstructing PML-induced premature senescence. EMBO J. 21:3358–3369.
   PubMedGoogle Scholar
• Bohren, K. M., V. Nadkarni, J. H. Song, K. H. Gabbay, and D. Owerbach. 2004. A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J. Biol. Chem. 279:27233–27238.
   PubMed Web of Science ®Google Scholar
• Clarke, N., N. Arenzana, T. Hai, A. Minden, and R. Prywes. 1998. Epidermal growth factor induction of the c-jun promoter by a Rac pathway. Mol. Cell. Biol. 18:1065–1073.
   PubMedGoogle Scholar
• Cox, D. M., M. Du, M. Marback, E. C. Yang, J. Chan, K. W. Siu, and J. C. McDermott. 2003. Phosphorylation motifs regulating the stability and function of myocyte enhancer factor 2A. J. Biol. Chem. 278:15297–15303.
   PubMedGoogle Scholar
• Cress, W. D., and E. Seto. 2000. Histone deacetylases, transcriptional control, and cancer. J. Cell. Physiol. 184:1–16.
   PubMed Web of Science ®Google Scholar
• Dequiedt, F., H. Kasler, W. Fischle, V. Kiermer, M. Weinstein, B. G. Herndier, and E. Verdin. 2003. HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis. Immunity 18:687–698.
   PubMed Web of Science ®Google Scholar
• Desterro, J. M., M. S. Rodriguez, and R. T. Hay. 1998. SUMO-1 modification of IκBα inhibits NF-κB activation. Mol. Cell 2:233–239.
   PubMed Web of Science ®Google Scholar
• Fischle, W., Y. Wang, and C. D. Allis. 2003. Binary switches and modification cassettes in histone biology and beyond. Nature 425:475–479.
   PubMed Web of Science ®Google Scholar
• Gill, G. 2004. SUMO and ubiquitin in the nucleus: different functions, similar mechanisms. Genes Dev. 18:2046–2059.
   PubMed Web of Science ®Google Scholar
• Girdwood, D., D. Bumpass, O. A. Vaughan, A. Thain, L. A. Anderson, A. W. Snowden, E. Garcia-Wilson, N. D. Perkins, and R. T. Hay. 2003. p300 transcriptional repression is mediated by SUMO modification. Mol. Cell 11:1043–1054.
   PubMedGoogle Scholar
• Girdwood, D. W., M. H. Tatham, and R. T. Hay. 2004. SUMO and transcriptional regulation. Semin. Cell Dev. Biol. 15:201–210.
   PubMed Web of Science ®Google Scholar
• Gong, X., X. Tang, M. Wiedmann, X. Wang, J. Peng, D. Zheng, L. A. Blair, J. Marshall, and Z. Mao. 2003. Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron 38:33–46.
   PubMed Web of Science ®Google Scholar
• Gregoretti, I. V., Y. M. Lee, and H. V. Goodson. 2004. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J. Mol. Biol. 338:17–31.
   PubMed Web of Science ®Google Scholar
• Grozinger, C. M., and S. L. Schreiber. 2002. Deacetylase enzymes: biological functions and the use of small-molecule inhibitors. Chem. Biol. 9:3–16.
   PubMed Web of Science ®Google Scholar
• Guo, D., M. Li, Y. Zhang, P. Yang, S. Eckenrode, D. Hopkins, W. Zheng, S. Purohit, R. H. Podolsky, A. Muir, et al. 2004. A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat. Genet. 36:837–841.
   PubMed Web of Science ®Google Scholar
• Han, J., Y. Jiang, Z. Li, V. V. Kravchenko, and R. J. Ulevitch. 1997. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386:296–299.
   PubMed Web of Science ®Google Scholar
• Han, J., and J. D. Molkentin. 2000. Regulation of MEF2 by p38 MAPK and its implication in cardiomyocyte biology. Trends Cardiovasc. Med. 10:19–22.
   PubMedGoogle Scholar
• Han, T.-H., and R. Prywes. 1995. Regulatory role of MEF2D in serum induction of the c-jun promoter. Mol. Cell. Biol. 15:2907–2915.
   PubMedGoogle Scholar
• Hietakangas, V., J. K. Ahlskog, A. M. Jakobsson, M. Hellesuo, N. M. Sahlberg, C. I. Holmberg, A. Mikhailov, J. J. Palvimo, L. Pirkkala, and L. Sistonen. 2003. Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1. Mol. Cell. Biol. 23:2953–2968.
   PubMed Web of Science ®Google Scholar
• Holmstrom, S., M. E. Van Antwerp, and J. A. Iniguez-Lluhi. 2003. Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy. Proc. Natl. Acad. Sci. USA 100:15758–15763.
   PubMed Web of Science ®Google Scholar
• Hook, S. S., A. Orian, S. M. Cowley, and R. N. Eisenman. 2002. Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes. Proc. Natl. Acad. Sci. USA 99:13425–13430.
   PubMed Web of Science ®Google Scholar
• Iniguez-Lluhi, J. A., and D. Pearce. 2000. A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy. Mol. Cell. Biol. 20:6040–6050.
   PubMedGoogle Scholar
• Ishov, A. M., A. G. Sotnikov, D. Negorev, O. V. Vladimirova, N. Neff, T. Kamitani, E. T. Yeh, J. F. Strauss III, and G. G. Maul. 1999. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147:221–234.
   PubMed Web of Science ®Google Scholar
• Kagey, M. H., T. A. Melhuish, and D. Wotton. 2003. The polycomb protein Pc2 is a SUMO E3. Cell 113:127–137.
   PubMed Web of Science ®Google Scholar
• Kasler, H. G., J. Victoria, O. Duramad, and A. Winoto. 2000. ERK5 is a novel type of mitogen-activated protein kinase containing a transcriptional activation domain. Mol. Cell. Biol. 20:8382–8389.
   PubMed Web of Science ®Google Scholar
• Kato, Y., V. V. Kravchenko, R. I. Tapping, J. Han, R. J. Ulevitch, and J.-D. Lee. 1997. BMK1/ERK5 regulate serum-induced early gene expression through transcription factor MEF2C. EMBO J. 16:7054–7066.
   PubMed Web of Science ®Google Scholar
• Kato, Y., M. Zhao, A. Morikawa, T. Sugiyama, D. Chakravortty, N. Koide, T. Yoshida, R. I. Tapping, Y. Yang, T. Yokochi, et al. 2000. Big mitogen-activated kinase regulates multiple members of the MEF2 protein family. J. Biol. Chem. 275:18534–18540.
   PubMedGoogle Scholar
• Khochbin, S., A. Verdel, C. Lemercier, and D. Seigneurin-Berny. 2001. Functional significance of histone deacetylase diversity. Curr. Opin. Genet. Dev. 11:162–166.
   PubMed Web of Science ®Google Scholar
• Kirsh, O., J. S. Seeler, A. Pichler, A. Gast, S. Muller, E. Miska, M. Mathieu, A. Harel-Bellan, T. Kouzarides, F. Melchior, et al. 2002. The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase. EMBO J. 21:2682–2691.
   PubMed Web of Science ®Google Scholar
• Kotaja, N., U. Karvonen, O. A. Janne, and J. J. Palvimo. 2002. PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol. Cell. Biol. 22:5222–5234.
   PubMed Web of Science ®Google Scholar
• Kouzarides, T. 2000. Acetylation: a regulatory modification to rival phosphorylation. EMBO J. 19:1176–1179.
   PubMed Web of Science ®Google Scholar
• Kovacs, J. J., C. Hubbert, and T. P. Yao. 2004. The HDAC complex and cytoskeleton. Novartis Found. Symp. 259:170–177.
   PubMedGoogle Scholar
• Li, X., S. Song, Y. Liu, S. H. Ko, and H. Y. Kao. 2004. Phosphorylation of the histone deacetylase 7 modulates its stability and association with 14-3-3 proteins. J. Biol. Chem. 279:34201–34208.
   PubMedGoogle Scholar
• Li, Y., H. Wang, S. Wang, D. Quon, Y. W. Liu, and B. Cordell. 2003. Positive and negative regulation of APP amyloidogenesis by sumoylation. Proc. Natl. Acad. Sci. USA 100:259–264.
   PubMed Web of Science ®Google Scholar
• Liu, F., M. Dowling, X.-J. Yang, and G. D. Kao. 2004. Caspase-mediated specific cleavage of human histone deacetylase 4. J. Biol. Chem. 279:34537–34546.
   PubMed Web of Science ®Google Scholar
• Long, J., G. Wang, D. He, and F. Liu. 2004. Repression of Smad4 transcriptional activity by SUMO modification. Biochem. J. 379:23–29.
   PubMedGoogle Scholar
• Mao, Z., A. Bonni, F. Xia, M. Nadal-Vicens, and M. E. Greenberg. 1999. Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science 286:785–790.
   PubMed Web of Science ®Google Scholar
• McKinsey, T. A., C. L. Zhang, and E. N. Olson. 2002. MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem. Sci. 27:40–47.
   PubMed Web of Science ®Google Scholar
• Melchior, F., M. Schergaut, and A. Pichler. 2003. SUMO: ligases, isopeptidases and nuclear pores. Trends Biochem. Sci. 28:612–618.
   PubMed Web of Science ®Google Scholar
• Miska, E. A., C. Karlsson, E. Langley, S. J. Nielsen, J. Pines, and T. Kouzarides. 1999. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J. 18:5099–5107.
   PubMed Web of Science ®Google Scholar
• Muller, S., C. Hoege, G. Pyrowolakis, and S. Jentsch. 2001. SUMO, ubiquitin's mysterious cousin. Nat. Rev. Mol. Cell Biol. 2:202–210.
   PubMed Web of Science ®Google Scholar
• Muller, S., M. J. Matunis, and A. Dejean. 1998. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 17:61–70.
   PubMed Web of Science ®Google Scholar
• Nathan, D., D. E. Sterner, and S. L. Berger. 2003. Histone modifications: now summoning sumoylation. Proc. Natl. Acad. Sci. USA 100:13118–13120.
   PubMedGoogle Scholar
• Nishida, T., H. Tanaka, and H. Yasuda. 2000. A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase. Eur. J. Biochem. 267:6423–6427.
   PubMedGoogle Scholar
• Paroni, G., M. Mizzau, C. Henderson, G. Del Sal, C. Schneider, and C. Brancolini. 2004. Caspase-dependent regulation of histone deacetylase 4 nuclear-cytoplasmic shuttling promotes apoptosis. Mol. Biol. Cell 15:2804–2818.
   PubMed Web of Science ®Google Scholar
• Petrie, K., F. Guidez, L. Howell, L. Healy, S. Waxman, M. Greaves, and A. Zelent. 2003. The histone deacetylase 9 gene encodes multiple protein isoforms. J. Biol. Chem. 278:16059–16072.
   PubMed Web of Science ®Google Scholar
• Pichler, A., A. Gast, J. S. Seeler, A. Dejean, and F. Melchior. 2002. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108:109–120.
   PubMed Web of Science ®Google Scholar
• Puri, P. L., V. Sartorelli, X.-J. Yang, Y. Hamamori, L. Kedes, A. Graessmann, Y. Nakatani, and M. Levrero. 1997. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol. Cell 1:35–45.
   PubMed Web of Science ®Google Scholar
• Reverter, D., and C. D. Lima. 2004. A basis for SUMO protease specificity provided by analysis of human Senp2 and a Senp2-SUMO complex. Structure (Cambridge) 12:1519–1531.
   PubMed Web of Science ®Google Scholar
• Rodriguez, M. S., C. Dargemont, and R. T. Hay. 2001. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276:12654–12659.
   PubMed Web of Science ®Google Scholar
• Ross, S., J. L. Best, L. I. Zon, and G. Gill. 2002. SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. Mol. Cell 10:831–842.
   PubMed Web of Science ®Google Scholar
• Sachdev, S., L. Bruhn, H. Sieber, A. Pichler, F. Melchior, and R. Grosschedl. 2001. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev. 15:3088–3103.
   PubMed Web of Science ®Google Scholar
• Seeler, J. S., and A. Dejean. 2003. Nuclear and unclear functions of SUMO. Nat. Rev. Mol. Cell Biol. 4:690–699.
   PubMed Web of Science ®Google Scholar
• Seigneurin-Berny, D., A. Verdel, S. Curtet, C. Lemercier, J. Garin, S. Rousseaux, and S. Khochbin. 2001. Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways. Mol. Cell. Biol. 21:8035–8044.
   PubMed Web of Science ®Google Scholar
• Sobko, A., H. Ma, and R. A. Firtel. 2002. Regulated SUMOylation and ubiquitination of DdMEK1 is required for proper chemotaxis. Dev. Cell 2:745–756.
   PubMedGoogle Scholar
• Soderling, T. R. 2000. CaM-kinases: modulators of synaptic plasticity. Curr. Opin. Neurobiol. 10:375–380.
   PubMed Web of Science ®Google Scholar
• Sterner, D. E., and S. L. Berger. 2000. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 64:435–459.
   PubMed Web of Science ®Google Scholar
• Subramanian, L., M. D. Benson, and J. A. Iniguez-Lluhi. 2003. A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3. J. Biol. Chem. 278:9134–9141.
   PubMed Web of Science ®Google Scholar
• Tatham, M. H., E. Jaffray, O. A. Vaughan, J. M. Desterro, C. H. Botting, J. H. Naismith, and R. T. Hay. 2001. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J. Biol. Chem. 276:35368–35674.
   PubMed Web of Science ®Google Scholar
• Vega, R. B., B. C. Harrison, E. Meadows, C. R. Roberts, P. J. Papst, E. N. Olson, and T. A. McKinsey. 2004. Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol. Cell. Biol. 24:8374–8385.
   PubMed Web of Science ®Google Scholar
• Verdin, E., F. Dequiedt, and H. G. Kasler. 2003. Class II histone deacetylases: versatile regulators. Trends Genet. 19:286–293.
   PubMed Web of Science ®Google Scholar
• Verger, A., J. Perdomo, and M. Crossley. 2003. Modification with SUMO: a role in transcriptional regulation. EMBO Rep. 4:137–142.
   PubMed Web of Science ®Google Scholar
• Wang, A. H., N. R. Bertos, M. Vezmar, N. Pelletier, M. Crosato, H. H. Heng, J. Th'ng, J. Han, and X.-J. Yang. 1999. HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol. Cell. Biol. 19:7816–7827.
   PubMed Web of Science ®Google Scholar
• Wang, A. H., M. J. Kruhlak, J. Wu, N. R. Bertos, M. Vezmar, B. I. Posner, D. P. Bazett-Jones, and X.-J. Yang. 2000. Regulation of histone deacetylase 4 by binding of 14-3-3 proteins. Mol. Cell. Biol. 20:6904–6912.
   PubMed Web of Science ®Google Scholar
• Wang, A. H., and X.-J. Yang. 2001. Histone deacetylase 4 possesses intrinsic nuclear import and export signals. Mol. Cell. Biol. 21:5992–6005.
   PubMed Web of Science ®Google Scholar
• Wang, L., C. Fan, S. E. Topol, E. J. Topol, and Q. Wang. 2003. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 302:1578–1581.
   PubMed Web of Science ®Google Scholar
• Xu, Q., L. Yu, L. Liu, C. F. Cheung, X. Li, S. K. Yee, X.-J. Yang, and Z. Wu. 2002. p38 mitogen-activated protein kinase-, calcium-calmodulin-dependent protein kinase-, and calcineurin-mediated signaling pathways transcriptionally regulate myogenin expression. Mol. Biol. Cell 13:1940–1952.
   PubMedGoogle Scholar
• Yang, C. C., O. I. Ornatsky, J. C. McDermott, T. F. Cruz, and C. A. Prody. 1998. Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1. Nucleic Acids Res. 26:4771–4777.
   PubMedGoogle Scholar
• Yang, X. J. 2004. Lysine acetylation and the bromodomain: a new partnership for signaling. BioEssays 26:1076–1087.
   PubMed Web of Science ®Google Scholar
• Yang, X.-J. 2005. Multisite protein modification and intramolecular signaling. Oncogene 10:1653–1662.
   Google Scholar
• Yang, X.-J., and E. Seto. 2003. Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression. Curr. Opin. Genet. Dev. 13:143–153.
   PubMed Web of Science ®Google Scholar
• Youn, H. D., L. Sun, R. Prywes, and J. O. Liu. 1999. Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2. Science 286:790–793.
   PubMed Web of Science ®Google Scholar
• Yuki, Y., I. Imoto, M. Imaizumi, S. Hibi, Y. Kaneko, T. Amagasa, and J. Inazawa. 2004. Identification of a novel fusion gene in a pre-B acute lymphoblastic leukemia with t(1;19)(q23;p13). Cancer Sci. 95:503–507.
   PubMed Web of Science ®Google Scholar
• Zhang, Y. 2003. Transcriptional regulation by histone ubiquitination and deubiquitination. Genes Dev. 17:2733–2740.
   PubMedGoogle Scholar
• Zhao, M., L. New, V. V. Kravchenko, Y. Kato, H. Gram, F. D. Padova, E. N. Olson, R. J. Ulevitch, and J. Han. 1998. Regulation of the MEF2 family of transcription factors by p38. Mol. Cell. Biol. 19:21–30.
   Google Scholar
• Zhu, B., and T. Gulick. 2004. Phosphorylation and alternative pre-mRNAsplicing converge to regulate myocyte enhancer factor 2C activity. Mol. Cell. Biol. 24:8264–8275.
   PubMedGoogle Scholar